Interobserver variation is a significant limitation in the diagnosis of Burkitt lymphoma

 

PDF Download Permissions and Reprints

Abstract

Context: The pathology of classic Burkitt lymphoma (BL) remains a challenge despite being a well-defined entity, in view of the significant overlap with atypical BL and B-cell lymphoma intermediate between DLBL (diffuse large B cell lymphoma) and BL. They are difficult to be segregated in resource-limited setups which lack molecular testing facilities. This is further affected by interobserver variability and experience of the reporting pathologist. Aims: The aim of our study was to quantitate variability among a group of pathologists with an interest in lymphomas (albeit with variable levels of experience) and quantitate the benefit of joint discussions as a tool to increase accuracy and reduce interobserver variability of pathologists, in the diagnosis of BL in a resource-limited setup. Materials and Methods: A set of 25 non-Hodgkin lymphoma cases in which a diagnosis of BL was entertained were circulated to 14 participating pathologist within the Mumbai lymphoma study group. A proforma recorded the morphologic and immunohistochemical features perceived during the initial independent diagnosis followed by a consensus meeting for discussion on morphology and additional information pertinent to the case. Statistical analysis and Results: The concordance was poor for independent diagnosis among all the pathologists with kappa statistics (±SE) of 0.168 (±0.018). Expert lymphoma pathologists had the highest (albeit only fair) concordance (kappa = 0.373 ± 0.071) and general pathologists the lowest concordance (kappa = 0.138 ± 0.035). Concordance for morphological diagnosis was highest among expert lymphoma pathologists (kappa = 0.356 ± 0.127). Revision of diagnoses after consensus meeting was highest for B-cell lymphoma intermediate between DLB and BL. To conclude, interobserver variation is a significant problem in BL in the post WHO 2008 classification era. Experience with a larger number of cases and joint discussion exercises such as the one we conducted are needed as they represent a simple and effective way of improving diagnostic accuracy of pathologists working in a resource-limited setup.

Publication History

Article published online:
19 July 2021

© 2014. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

• References

• 1 El-Zimaity HM, Wotherspoon A, de Jong D, Houston MALT lymphoma Workshop. Interobserver variation in the histopathological assessment of malt/malt lymphoma: Towards a consensus. Blood Cells Mol Dis 2005;34:6-16.
• 2 Magrath I. Treatment of Burkitt lymphoma in children and adults: Lessons from Africa. Curr Hematol Malig Rep 2006;1:230-40.
• 3 Braziel RM, Arber DA, Slovak ML, Gulley ML, Spier C, Kjeldsberg C, et al. The Burkitt-like lymphomas: A Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood 2001;97:3713-20.
• 4 Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, et al. Molecular Diagnosis of Burkitt′s Lymphoma. N Engl J Med 2006;354:2431-42.
• 5 Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, et al. A Biologic Definition of Burkitt′s Lymphoma from Transcriptional and Genomic Profiling. N Engl J Med 2006;354:2419-30.
• 6 Lones MA, Auperin A, Raphael M, McCarthy K, Perkins SL, MacLennan KA, et al. Mature B-cell lymphoma/leukemia in children and adolescents: Intergroup pathologist consensus with the revised European-American Lymphoma Classification. Ann Oncol 2000;11:47-51.
• 7 Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: Importance to epidemiology. Arch Pathol Lab Med 2011;135:445-50.
• 8 Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Muller-Hermelink HK, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005;29:1086-94.
• 9 Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach - applicable in both resource-poor and resource-rich countries. Br J Haematol 2011;154:770-6.